Production (Stage)
Amedisys, Inc.
AMED
$93.43
-$0.13-0.14%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 536.28% | 543.53% | 3,031.95% | 3,847.77% | -118.36% |
| Total Depreciation and Amortization | 5.44% | 4.89% | 2.69% | -4.36% | -10.83% |
| Total Amortization of Deferred Charges | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Non-Cash Items | -75.53% | -49.12% | -71.44% | -67.03% | 232.96% |
| Change in Net Operating Assets | 141.21% | 163.12% | 130.22% | -3.28% | 24.34% |
| Cash from Operations | 114.47% | 61.58% | 79.77% | -15.57% | -5.37% |
| Capital Expenditure | 26.59% | -16.55% | -31.99% | -13.12% | -4.94% |
| Sale of Property, Plant, and Equipment | -88.97% | -- | -64.00% | -72.09% | 368.97% |
| Cash Acquisitions | -- | -- | 100.00% | -100.00% | 100.00% |
| Divestitures | -- | -- | -100.00% | -100.00% | -100.00% |
| Other Investing Activities | 77.59% | 73.67% | 72.91% | 88.99% | -402.55% |
| Cash from Investing | 52.01% | -123.85% | -125.89% | -121.92% | 57.25% |
| Total Debt Issued | -- | -- | -100.00% | -100.00% | -97.24% |
| Total Debt Repaid | 14.52% | 62.27% | 77.43% | 90.21% | 92.65% |
| Issuance of Common Stock | -78.69% | -88.56% | -98.21% | -83.58% | -68.02% |
| Repurchase of Common Stock | -43.87% | 5.77% | -56.49% | -7.89% | 73.41% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -34.46% | 25.51% | -258.54% | 18.59% | -671.47% |
| Cash from Financing | -36.98% | 44.10% | 43.45% | 51.27% | 50.97% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 218.15% | 94.00% | 142.08% | -25.96% | 2,952.63% |